ArticleJCI insight2020
BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination.
Hyunkyung Jung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it